Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback